PR Newswire - DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMEN...
Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient The ACTION3 Phase 3 trial explores the efficacy and safe...
Read More

ภาษาไทย
English